FDA to Review Roche RT-PCR Dx for HIV, Hepatitis in Donated Blood and Plasma | GenomeWeb
NEW YORK (GenomeWeb News) — The US Food and Drug Administration will review a Roche Diagnostics test designed to diagnose HIV and hepatitis infections in donated blood and plasma, Roche said Wednesday.
 
The cobas TaqScreen MPX test is a real-time PCR-based single-multiplex assay that if approved would be used to detect HIV types 1 and 2 and hepatitis viruses C and B.
 
The tests would function on Roche’s cobas s 201 platform.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.